We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Why Lloyds Banking Group PLC, PZ Cussons plc And DS Smith plc Are Genuine Blue-Chip Bargains

Royston Wild explains why value hunters should be sniffing around Lloyds Banking Group PLC (LON: LLOY), PZ Cussons plc (LON: PZC) and DS Smith plc (LON: SMDS).

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

Today I am looking at three FTSE giants that offer spectacular bang for one’s buck.

Lloyds Banking Group

I believe that Lloyds (LSE: LLOY) is in great shape to deliver delicious shareholder returns as the British economy steadily gathers momentum. While it’s true the PPI mis-selling scandal will remain problematic for some time yet — the business has already set aside a colossal £13bn to cover claims — I believe the effect of asset sales, cost-cutting, and a re-energised focus on the High Street leaves the bank a much more efficient earnings-generating machine for the years ahead.

Should you buy Lloyds Banking Group Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

It is certainly true that the bottom-line is not expected to take off any time soon. Indeed, earnings are expected to rise 5% in 2015 before slipping 6% in 2016. But Lloyds’ de-risking exercise of recent years at least makes it a better pick than many of its rivals for those seeking stable earnings performance further out. And rock-bottom P/E ratios of 8.7 times for this year and 9.7 times for 2016 are hard to ignore.

And with the balance sheet steadily improving — Lloyds’ CET1 capital ratio clocked in at a healthy 13.3% as of June — dividends are expected to explode in the coming years, too. The City expects a touted dividend of 2.5p per share for 2015, yielding a decent 3.4%, to leap to 3.9p in 2016, pushing the yield to a market-busting 5.2%.

PZ Cussons

Concerns over slowing demand from emerging markets has forced market appetite for PZ Cussons (LSE: PZC) through the floor more recently — indeed, the company’s share price has shed 20% in the past three months alone. But I believe this presents a fresh stocking-up opportunity, as I reckon the long-term potential of these territories should deliver brilliant long-term rewards for the company.

Indeed, PZ Cussons is a major player across Africa and Asia in particular, thanks in no small part to products like Carex soap and Yo cooking oil, labels that carry formidable pricing power to keep sales chugging higher. And with regular product roll-outs maintaining consumer interest, PZ Cussons is expected to enjoy earnings growth of 2% and 8% in the years ending May 2016 and 2017 respectively, resulting in decent P/E ratios of 16 times and 15.1 times.

This strong growth outlook is also expected to keep the dividend jogging comfortably higher, too. A payment of 8.4p per share is currently forecast for this year, yielding a very handy 2.9%. And this figure moves to 3% next year thanks to predictions of an 8.9p dividend.

DS Smith

Box building play DS Smith (LSE: SMDS) has forged itself a reputation as a dependable deliver of double-digit earnings rises in recent years, with retailers champing at the bit to snap up the firm’s innovative packaging solutions. And I reckon the company’s strong position across Europe should continue to underpin solid bottom-line growth — indeed, DS Smith has snapped up Duropack and Grupo Lantero in recent months to bulk up its presence in both established and developing continental markets.

Even though DS Smith is expected to see earnings expansion slow to 6% for the year concluding April 2016, the number crunchers expect growth to bounce higher again from next year — indeed, a 12% advance is currently pencilled in. These figures leave the packaging giant changing hands on very appealing P/E ratios of 15.5 times for 2016 and 13.8 times for the following year.

Naturally this bubbly earnings picture is expected to keep dividends trucking, as well. Last year’s reward of 11.4p per share is anticipated to leap to 12.3p for 2016, creating a yield of 3.1%. And predictions of a 13.4p dividend for 2017 nudges the yield to 3.3%.

Royston Wild owns shares of DS Smith. The Motley Fool UK owns shares of PZ Cussons. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

A rear view of a female in a bright yellow coat walking along the historic street known as The Shambles in York, UK which is a popular tourist destination in this Yorkshire city.
Investing Articles

At 8.1%, are investors missing the bigger story behind Legal & General shares?

Andrew Mackie explores Legal & General shares and asks whether investors are still viewing it too narrowly as a yield…

Read more »

Young black female footballer training on stadium pitch
Investing Articles

How has this FTSE 250 share surged ANOTHER 7% today?

Applied Nutrition shares have soared on Monday after another brilliant trading update. So what's the FTSE 250 company's secret?

Read more »

Black woman using smartphone at home, watching stock charts.
Investing Articles

The stock market game you’re actually playing (and why you might be losing)

Our writer recounts a painful experience of making a rash stock market decision based on emotions, not logic – and…

Read more »

Aerial shot showing an aircraft shadow flying over an idyllic beach
Investing Articles

Why is EasyJet stock suddenly a takeover target for US investors?

Andrew Mackie looks at easyjet shares jumping on US takeover talk — but is this a genuine re-rating or just…

Read more »

Young Black woman looking concerned while in front of her laptop
Investing Articles

Have investors got BT shares all wrong?

BT shares spiked during the 1990s telecom boom, then struggled for two decades. Harvey Jones says it's the future that…

Read more »

BUY AND HOLD spelled in letters on top of a pile of books. Alongside is a piggy bank in glasses. Buy and hold is a popular long term stock and shares strategy.
Investing Articles

Looking for buying opportunities in June? Here’s 1 to consider from my Stocks and Shares ISA

The conflict in Iran is making one of the investments in Stephen Wright’s Stocks and Shares ISA volatile. But could…

Read more »

Row of blue European Union flags in Brussels.
Investing Articles

After crashing 13.7% today, is Wise now a stock market bargain at 805p?

Wise was one of the biggest fallers on the UK stock market today. What on earth is going on with…

Read more »

Road 2025 to 2032 new year direction concept
Investing Articles

At 8% is this eye-popping FTSE 100 dividend yield simply too good to be true?

The dividend yield is to die for, but the share price is lacking in life. Harvey Jones examines whether this…

Read more »